Valuation: Novartis AG

Market Cap 268B 238B 223B 202B 381B 25,846B 384B 2,675B 1,040B 13,185B 1,006B 985B 42,386B P/E 2026 *
19.9x
P/E 2027 * 16.7x
Enterprise Value 300B 266B 249B 226B 426B 28,881B 429B 2,989B 1,163B 14,734B 1,125B 1,100B 47,365B EV / Sales 2026 *
5.19x
EV / Sales 2027 * 4.83x
Free-Float
91.66%
Yield 2026 *
3.07%
Yield 2027 * 3.21%
1 day+0.60%
1 week-3.09%
Current month-2.32%
1 month-9.57%
3 months-6.33%
6 months-4.89%
Current year+6.92%
1 week 115.94
Extreme 115.94
119.38
1 month 110.3
Extreme 110.3
122.54
Current year 107.68
Extreme 107.68
132.68
1 year 97.05
Extreme 97.05
132.68
3 years 81.1
Extreme 81.1
132.68
5 years 72.84
Extreme 72.84
132.68
10 years 65.09
Extreme 65.09
132.68
Manager TitleAgeSince
Chief Executive Officer 50 2018-01-31
Director of Finance/CFO - 2026-03-15
Compliance Officer 58 2025-04-13
Director TitleAgeSince
Director/Board Member 67 2014-12-31
Director/Board Member 69 2015-12-31
Director/Board Member 61 2015-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
5/18/26 Sell -5,200 0.0003%
5/4/26 Sell 6,800 0.0003%
2/17/26 Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+0.60%-3.09%+10.76%+32.59% 266B
+1.26%-2.29%+36.97%+104.79% 1,019B
+0.73%-4.78%+35.41%+61.62% 610B
+0.35%+1.29%+15.86%+79.90% 470B
+1.72%-4.92%+59.84%+36.64% 344B
+0.26%+0.14%+21.29%+40.99% 336B
+1.65%-3.78%-6.03%+9.29% 241B
-0.09%-4.97%+36.88%+50.52% 218B
-0.28%-4.66%+26.99%+92.98% 179B
-0.51%-2.42%-36.48%-61.95% 164B
Average +0.29%-3.56%+20.15%+44.74% 384.66B
Weighted average by Cap. +0.03%-3.38%+26.71%+61.53%

Financials

2026 *2027 *
Net sales 57.69B 51.21B 47.92B 43.44B 82.04B 5,561B 82.63B 576B 224B 2,837B 217B 212B 9,120B 61.39B 54.5B 51B 46.23B 87.3B 5,918B 87.93B 613B 238B 3,019B 230B 225B 9,706B
Net income 14.47B 12.85B 12.02B 10.9B 20.58B 1,395B 20.73B 144B 56.17B 712B 54.33B 53.17B 2,288B 16.1B 14.29B 13.37B 12.12B 22.89B 1,552B 23.05B 161B 62.46B 792B 60.42B 59.12B 2,545B
Net Debt 31.49B 27.96B 26.16B 23.71B 44.78B 3,036B 45.11B 314B 122B 1,549B 118B 116B 4,979B 28.29B 25.11B 23.5B 21.3B 40.23B 2,727B 40.52B 282B 110B 1,391B 106B 104B 4,472B
Projected Income Statement - Annual - Novartis AG
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
26-10-06 CHF 117.18 +0.60% 2,334,112
26-10-05 CHF 116.48 +0.12% 2,407,594
26-10-02 CHF 116.34 -1.46% 2,595,469
26-10-01 CHF 118.06 -1.58% 2,820,997
26-09-30 CHF 119.96 -0.79% 4,258,547
Trader
Investor
Global
Quality
ESG MSCI
AAA
Ratings Surperformance© - Novartis AG
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
23
Last Close Price
141.06USD
Average target price
150.94USD
Spread / Average Target
+7.01%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Novartis AG
  1. Stock Market
  2. Stocks
  3. NOVN Stock